SOPHiA GENETICS (SOPH) Long-Term Deferred Tax (2020 - 2025)

SOPHiA GENETICS has disclosed Long-Term Deferred Tax across 6 years of filings, most recently posting $1.8 million for Q4 2025.

• Long-Term Deferred Tax for Q4 2025 came in at $1.8 million, up 3.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (up 3.62% YoY), and the FY2025 annual result was $1.8 million, up 3.62% from the prior year.
• Long-Term Deferred Tax came in at $1.8 million for Q4 2025 at SOPHiA GENETICS, up from $1.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.0 million in Q2 2021 to a low of $1.6 million in Q3 2022.
• The 5-year median for Long-Term Deferred Tax is $1.8 million (2024), against an average of $1.8 million.
• Across the five-year window, Long-Term Deferred Tax decreased 18.77% in 2022 and advanced 23.81% in 2023, its largest moves.
• SOPHiA GENETICS's Long-Term Deferred Tax stood at $2.0 million in 2021, then slipped by 2.51% to $1.9 million in 2022, then dropped by 11.34% to $1.7 million in 2023, then rose by 2.73% to $1.8 million in 2024, then advanced by 3.62% to $1.8 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $1.8 million (Q4 2025), $1.7 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.